Cipla's arm completes acquisition of stake in Wellthy Therapeutics

11 Mar 2019 Evaluate

Cipla's wholly owned subsidiary -- Goldencross Pharma has completed the closing of Wellthy Therapeutics, transaction representing an acquisition of 11.71% stake in Wellthy on fully diluted basis on March 08, 2019.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients. The company’s portfolio includes over 1500 products across wide range of therapeutic categories with one quality standard globally.

Cipla Share Price

1511.05 -9.50 (-0.62%)
08-Dec-2025 11:20 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.05
Dr. Reddys Lab 1274.50
Cipla 1511.05
Zydus Lifesciences 931.60
Lupin 2082.55
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×